Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress

IF 3.3 3区 医学 Q2 PHARMACOLOGY & PHARMACY Pulmonary pharmacology & therapeutics Pub Date : 2023-09-17 DOI:10.1016/j.pupt.2023.102259
Yanhong Han, Chuang Ge, Junmei Ye, Ruiyan Li, Yubin Zhang
{"title":"Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress","authors":"Yanhong Han,&nbsp;Chuang Ge,&nbsp;Junmei Ye,&nbsp;Ruiyan Li,&nbsp;Yubin Zhang","doi":"10.1016/j.pupt.2023.102259","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><span>Acute pneumonia induced by </span><span><em>Pseudomonas aeruginosa</em></span><span> is characterized by massive infiltration of inflammatory cell<span> and the production of reactive oxygen species<span> (ROS), which lead to severe and transient pulmonary inflammation and acute lung injury. However, </span></span></span><em>P.aeruginosa</em> infection is resistant to multiple antibiotics and causes high mortality in clinic, the search for alternative prophylactic and therapeutic strategies is imperative.</p></div><div><h3>Purpose</h3><p><span><span>This study was aimed to investigate the anti-inflammatory and antioxidant effects of DMB, a novel derivative of berberine, and explore the role of </span>AIM2<span> inflammasome in </span></span><em>P. aeruginosa</em>-induced acute pneumonia.</p></div><div><h3>Methods</h3><p>Acute pneumonia mice were established by tracheal injection of <em>P. aeruginosa</em><span><span> suspension. Pathological changes of lung tissue were observed by its appearance and H&amp;E staining. The lung coefficient ratio was measured to evaluate pulmonary edema<span>. Inflammatory factors were detected by qRT-PCR, western blotting and </span></span>immunohistochemistry. ROS and other indicators of oxidative damage were analyzed by flow cytometry and specific kit. Proteins related to AIM2 inflammasome were detected by western blotting.</span></p></div><div><h3>Results</h3><p>Compared with the <em>P. aeruginosa</em><span>-induced group, DMB ameliorated pulmonary edema, hyperemia, and pathological damage based on its appearance and H&amp;E staining in DMB groups. First, DMB attenuated the inflammatory response induced by </span><em>P.aeruginosa</em>. Compared with the <em>P. aeruginosa</em><span><span>-induced group, the lung coefficient ratio was decreased by 31.5%, the MPO activity of lung tissue was decreased by 44.0%, the mRNA expression levels of TNF-α, IL-1β and IL-6 were decreased by 64.8%, 51.2% and 64.0% respectively, and those protein expression levels were decreased by 40.1%, 42.8% and 47.8% respectively, and the number of white blood cells, </span>neutrophils<span> and monocytes<span> were decreased by 53.5%, 29.4% and 13.7% in high dose (200 mg/kg) DMB group. Second, DMB alleviates oxidative stress in the lung tissue during </span></span></span><em>P. aeruginosa</em>-induced acute pneumonia. Compared with the <em>P. aeruginosa</em>-induced group, the level of GSH was increased by 42.5% and MDA was decreased by 49.5% in high dose DMB group. Moreover, the western blotting results showed that DMB markedly suppressed the expression of AIM2, ASC, Cleaved caspase1 and decreased the secretion of IL-1β. Additionally, these results were also confirmed by <em>in vitro</em> experiments using MH-S and BEAS-2B cell lines.</p></div><div><h3>Conclusions</h3><p>Taken together, these results indicated that DMB ameliorates <em>P. aeruginosa</em>-induced acute pneumonia through anti-inflammatory, antioxidant effects, and inhibition of AIM2 inflammasome activation.</p></div>","PeriodicalId":20799,"journal":{"name":"Pulmonary pharmacology & therapeutics","volume":"83 ","pages":"Article 102259"},"PeriodicalIF":3.3000,"publicationDate":"2023-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary pharmacology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094553923000718","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Acute pneumonia induced by Pseudomonas aeruginosa is characterized by massive infiltration of inflammatory cell and the production of reactive oxygen species (ROS), which lead to severe and transient pulmonary inflammation and acute lung injury. However, P.aeruginosa infection is resistant to multiple antibiotics and causes high mortality in clinic, the search for alternative prophylactic and therapeutic strategies is imperative.

Purpose

This study was aimed to investigate the anti-inflammatory and antioxidant effects of DMB, a novel derivative of berberine, and explore the role of AIM2 inflammasome in P. aeruginosa-induced acute pneumonia.

Methods

Acute pneumonia mice were established by tracheal injection of P. aeruginosa suspension. Pathological changes of lung tissue were observed by its appearance and H&E staining. The lung coefficient ratio was measured to evaluate pulmonary edema. Inflammatory factors were detected by qRT-PCR, western blotting and immunohistochemistry. ROS and other indicators of oxidative damage were analyzed by flow cytometry and specific kit. Proteins related to AIM2 inflammasome were detected by western blotting.

Results

Compared with the P. aeruginosa-induced group, DMB ameliorated pulmonary edema, hyperemia, and pathological damage based on its appearance and H&E staining in DMB groups. First, DMB attenuated the inflammatory response induced by P.aeruginosa. Compared with the P. aeruginosa-induced group, the lung coefficient ratio was decreased by 31.5%, the MPO activity of lung tissue was decreased by 44.0%, the mRNA expression levels of TNF-α, IL-1β and IL-6 were decreased by 64.8%, 51.2% and 64.0% respectively, and those protein expression levels were decreased by 40.1%, 42.8% and 47.8% respectively, and the number of white blood cells, neutrophils and monocytes were decreased by 53.5%, 29.4% and 13.7% in high dose (200 mg/kg) DMB group. Second, DMB alleviates oxidative stress in the lung tissue during P. aeruginosa-induced acute pneumonia. Compared with the P. aeruginosa-induced group, the level of GSH was increased by 42.5% and MDA was decreased by 49.5% in high dose DMB group. Moreover, the western blotting results showed that DMB markedly suppressed the expression of AIM2, ASC, Cleaved caspase1 and decreased the secretion of IL-1β. Additionally, these results were also confirmed by in vitro experiments using MH-S and BEAS-2B cell lines.

Conclusions

Taken together, these results indicated that DMB ameliorates P. aeruginosa-induced acute pneumonia through anti-inflammatory, antioxidant effects, and inhibition of AIM2 inflammasome activation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
去甲烯黄连素通过抑制AIM2炎症小体和氧化应激来减轻铜绿假单胞菌诱导的急性肺炎。
背景:铜绿假单胞菌诱导的急性肺炎以炎症细胞大量浸润和活性氧(ROS)的产生为特征,可导致严重和短暂的肺部炎症和急性肺损伤。然而,铜绿假单胞菌感染对多种抗生素具有耐药性,在临床上导致高死亡率,寻找替代的预防和治疗策略势在必行。目的:本研究旨在研究黄连素的新衍生物DMB的抗炎和抗氧化作用,并探讨AIM2炎症小体在铜绿假单胞菌诱导的急性肺炎中的作用。方法:气管注射铜绿假单胞菌混悬液建立急性肺炎小鼠模型。通过肺组织的外观和H&E染色观察肺组织的病理变化。测量肺系数比值以评估肺水肿。采用qRT-PCR、蛋白质印迹和免疫组织化学方法检测炎症因子。通过流式细胞术和特异性试剂盒分析ROS和其他氧化损伤指标。免疫印迹法检测AIM2炎症小体相关蛋白。结果:与铜绿假单胞菌诱导组相比,DMB组的外观和H&E染色显示,DMB改善了肺水肿、充血和病理损伤。首先,DMB减轻了铜绿假单胞菌诱导的炎症反应。与铜绿假单胞杆菌诱导组相比,肺系数比下降31.5%,肺组织MPO活性下降44.0%,TNF-α、IL-1β和IL-6的mRNA表达水平分别下降64.8%、51.2%和64.0%,蛋白质表达水平下降40.1%,高剂量(200mg/kg)DMB组白细胞、中性粒细胞和单核细胞的数量分别减少了53.5%、29.4%和13.7%。其次,DMB在铜绿假单胞菌诱导的急性肺炎期间减轻肺组织中的氧化应激。与铜绿假单胞菌诱导组相比,高剂量DMB组GSH水平升高42.5%,MDA水平降低49.5%。此外,蛋白质印迹结果显示,DMB显著抑制AIM2、ASC、Cleaved caspase1的表达,并降低IL-1β的分泌。此外,使用MH-S和BEAS-2B细胞系的体外实验也证实了这些结果。结论:总之,这些结果表明DMB通过抗炎、抗氧化和抑制AIM2炎症小体激活来改善铜绿假单胞菌诱导的急性肺炎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
41
审稿时长
42 days
期刊介绍: Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews. Research Areas Include: • All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary Toxicology.
期刊最新文献
Triple inhaled therapy in asthma: beliefs, behaviours and doubts. Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1